Search

everythinglearnresearchcommunity

for

Search:↓

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

Limelight (CB-EVs) safely promotes hair growth.

Near-infrared LED light improves skin rejuvenation and hair growth better than white LED light.

Blue light might help treat skin conditions by affecting the skin's bacteria.

HSD11b1 affects skin nerves and increases non-histaminergic itch.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Using isotretinoin gel and minoxidil solution together effectively regrows hair in most people with patchy hair loss.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Lichen planopilaris can occur with multiple autoimmune diseases.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

PPARα agonists may help treat alopecia areata by reducing inflammation.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Innovative methods are reducing animal testing and improving biomedical research.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

A new microneedle patch made from hair proteins helps regrow hair faster and better than current treatments.